AMAYA
HILARIO BARRIO
Profesor asociado de Ciencias de la Salud
Instituto de Salud Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (2)
2020
-
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)
Targeted Oncology, Vol. 15, Núm. 5, pp. 613-622
2019
-
Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab
Clinical and Translational Oncology, Vol. 21, Núm. 10, pp. 1413-1423